Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury.
2007
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
2010
Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A
2008
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Astrocytes: biology and pathology
2009 Standout
A pupal transcriptomic screen identifies Ral as a target of store-operated calcium entry in Drosophila neurons
2017 StandoutNobel
Molecular mechanisms of L-DOPA-induced dyskinesia
2008
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
2008
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
2007
Neural mechanism underlying acupuncture analgesia
2008 Standout
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
A comprehensive map of molecular drug targets
2016 Standout
Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine
2004
Descending control of pain
2002 Standout
Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
2008
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
2012 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
2010
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
2009 StandoutNobel
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
2016
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic Agent
2001
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
2007 Standout
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Psychedelics
2016 Standout
Potentiation of the antinociceptive effect of clomipramine by a 5‐ht1A antagonist in neuropathic pain in rats
2001
Changes in anxiety-related behaviors and hypothalamic–pituitary–adrenal activity in mice lacking the 5-HT-3A receptor
2004 StandoutNobel
Effects of the CRF1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups
2000
Glial responses to implanted electrodes in the brain
2017
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
2007
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
2017
Constitutive Activity of the Serotonin2C Receptor InhibitsIn VivoDopamine Release in the Rat Striatum and Nucleus Accumbens
2004
Acute Selective Serotonin Reuptake Inhibitors Increase Conditioned Fear Expression: Blockade With a 5-HT2C Receptor Antagonist
2007
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Ondansetron: A Selective 5‐HT3Receptor Antagonist and Its Applications in CNS‐Related Disorders
2001
Astrocytes Induce Hemeoxygenase-1 Expression in Microglia: A Feasible Mechanism for Preventing Excessive Brain Inflammation
2006
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
2011
5-HT3 receptor antagonists and anxiety; a preclinical and clinical review
2000
The Gerbil Elevated Plus-Maze I Behavioral Characterization and Pharmacological Validation
2002
The Selective Serotonin2A Receptor Antagonist, MDL100,907, Elicits a Specific Interoceptive Cue in Rats
2002
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Stimulation of 5‐hydroxytryptamine (5‐HT2C) receptors in the ventrotegmental area inhibits stress‐induced but not basal dopamine release in the rat prefrontal cortex
2002
Activation of Extrasynaptic, But Not Synaptic, NMDA Receptors Modifies Amyloid Precursor Protein Expression Pattern and Increases Amyloid-β Production
2010
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors
2002
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats
2000
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
2013 Standout
Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
2010
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
2010
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
Major Depressive Disorder
2008 Standout
The neural basis of psychedelic action
2022 Standout
Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats
2007
Light‐Controlled Formation of Vesicles and Supramolecular Organogels by a Cholesterol‐Bearing Amphiphilic Molecular Switch
2014 StandoutNobel
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion
2004
Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice
2005
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
2011 StandoutNobel
Gender and Iron Genes May Modify Associations Between Brain Iron and Memory in Healthy Aging
2011
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways
2003
Review of the Pharmacology and Clinical Profile of Bupropion, an Antidepressant and Tobacco Use Cessation Agent
2006
5-HT1A receptors are involved in the anxiolytic effect of Δ9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague–Dawley rats
2006
Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition
2008
Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
2003
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade
2004
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
Lipid raft microdomains and neurotransmitter signalling
2006
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Parkinson's Disease
2003 Standout
Differential Effects of Aripiprazole on D 2 , 5-HT 2 , and 5-HT 1A Receptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study
2007
Neurochemistry of Parkinson's disease
2007
Development of allosteric modulators of GPCRs for treatment of CNS disorders
2013
Animal Models of Serotonergic Psychedelics
2012
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Pd-catalyzed oxidative C–H alkenylation for synthesizing arylvinyltriazole nucleosides
2014
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Impaired glutamate recycling and GluN2B‐mediated neuronal calcium overload in mice lacking TGF‐β1 in the CNS
2013
Multiple Sclerosis
2018 Standout
Inflammation after Intracerebral Hemorrhage
2006
Hydrogel bioelectronics
2018 Standout
Deep Brain Stimulation
2015
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
The anabolic–androgenic steroid nandrolone induces alterations in the density of serotonergic 5ht1b and 5ht2 receptors in the male rat brain
2003
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
2012
About Sleep's Role in Memory
2013 Standout
Overexpression of Alpha2C-adrenoceptors impairs water maze navigation
1999
Serotonin Receptors
2008
Effects of Antisense to the α2A-Adrenoceptors Administered into the Region of the Locus Ceruleus on Behaviors in Plus-Maze and Sexual Behavior Tests in Sham-Operated and Castrated Male Rats
2001
Modulation of dopamine release by striatal 5‐HT2C receptors
2005
2015
Coupling of the NMDA receptor to neuroprotective and neurodestructive events
2009
AN INTEGRATIVE THEORY OF LOCUS COERULEUS-NOREPINEPHRINE FUNCTION: Adaptive Gain and Optimal Performance
2005 Standout
Physiology of Microglia
2011 Standout
Works of Christophe Melon being referenced
Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation
2009
Forelimb dyskinesia mediated by high‐frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit ofN‐methyl‐d ‐aspartate receptors
2010
Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
2006
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra
2014
α2‐Adrenergic Receptor Blockade Markedly Potentiates Duloxetine‐ and Fluoxetine‐Induced Increases in Noradrenaline, Dopamine, and Serotonin Levels in the Frontal Cortex of Freely Moving Rats
1997
High frequency stimulation of the subthalamic nucleus impacts adult neurogenesis in a rat model of Parkinson's disease
2011
Chronic l ‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
2004
Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies
2009
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of α2-adrenergic receptors underlie its actions
1999
Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
2012
Effects of prolonged iron overload and low frequency electromagnetic exposure on spatial learning and memory in the young rat
2009
Glial soluble factors regulate the activity and expression of the neuronal glutamate transporter EAAC1: implication of cholesterol
2004
The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test
1998
WAY 100,635 enhances both the `antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex
1998
Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
2000
High-Frequency Stimulation of the Subthalamic Nucleus Potentiates l-DOPA-Induced Neurochemical Changes in the Striatum in a Rat Model of Parkinson's Disease
2007
5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat
2004
Cellular and Behavioral Outcomes of Dorsal Striatonigral Neuron Ablation: New Insights into Striatal Functions
2014
Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction
2007
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats
2001
Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson’s disease
2008
Enhanced delivery of γ-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy
2005
S-16924, a Novel, Potential Antipsychotic with Marked Serotonin1A Agonist Properties. IV. A Drug Discrimination Comparison with Clozapine
1999